当前位置: 首页 > 期刊 > 《中国实用医药》 > 2019年第35期
编号:13433006
预防措施改进对骨折患者深静脉血栓形成的影响(3)
http://www.100md.com 2019年12月15日 《中国实用医药》 2019年第35期
     [17] Gerhart TN, Yett HS, Robertson LK, et al. Low-molecular-weight heparinoid compared with warfarin for prophylaxis of deep-vein thrombosis in patients who are operated on for fracture of the hip. A prospective, randomized trial. 1991, 73(4):494-502.

    [18] Dhillon KS , Askander A , Doraismay S . Postoperative deep-vein thrombosis in Asian patients is not a rarity: A prospective study of 88 patients with no prophylaxis. The Bone & Joint Journal, 1996, 78(3):427-430.

    [19] Fredin HO, Nillius SA, Bergqvist D. Prophylaxis of Deep Vein Thrombosis in Patients with Fracture of the Femoral Neck:\\r, A Prospective Comparison between Dextran and a Sulphated Polysaccharide. Acta Orthopaedica Scandinavica, 2004, 53(3):413-417.

    [20] Lewandowski K, Szturmowicz M, Fija?kowska A, et al. Pulmonary embolism in course of deep vein thrombosis of lower extremities in patient wit bilateral femoral bone fracture after car accident injuries. 2002, 70(3-4):203.

    [收稿日期:2019-09-28], 百拇医药(杨有岗 王礼鹏 杨建军)
上一页1 2 3